Moreover, a mouse skin tumor model where cells expressed 4-hydroxytamoxifen-regulated ROCK, which consists of ROCK kinase domain and estrogen receptor under control of cytokeratin 14 promoter [44], revealed a relationship between ROCK-induced cytoskeletal rearrangement and tumor progression [44]. The gene discussed is ESR1; the disease is skin neoplasm.